Chromate-induced human erythrocytes haemoglobin oxidation and peroxidation: influence of vitamin E, vitamin C, salicylate, deferoxamine, and N-ethylmaleimide
Mas. Fernandes et al., Chromate-induced human erythrocytes haemoglobin oxidation and peroxidation: influence of vitamin E, vitamin C, salicylate, deferoxamine, and N-ethylmaleimide, TOX LETT, 114(1-3), 2000, pp. 237-243
In order to attenuate or to prevent chromate-induced human erythrocytes inj
ury, the influence of Vitamin E, vitamin C, salicylate, deferoxamine, and N
-ethylmaleimide on chromate-induced human erythrocytes haemoglobin oxidatio
n and peroxidation were investigated. It was observed that pretreatment of
human erythrocytes with vitamin E (20 mu M), vitamin C (1 mM), salicylate (
3 mM), and deferoxamine (4 mM) significantly increased (P = 0.0001) chromat
e-induced human erythrocytes haemoglobin oxidation in a time dependent mann
er, while it was significantly decreased (P = 0.0001) by pretreatment with
N-ethylmaleimide (1 mM). In contrast, pretreatment of human erythrocytes wi
th deferoxamine (4 mM) immediately inhibited (P = 0.0001) chromate-induced
human erythrocytes peroxidation, while it was significantly increased (P =
0.0001) by pretreatment with N-ethylmaleimide (1 mM) during the first 4 h o
f cells exposition to chromate. For time periods superior to 6 h pretreatme
nt with N-ethylmaleimide (1 mM) significantly decreased (P = 0.0001) chroma
te-induced human erythrocytes peroxidation. It was concluded that care must
be taken as these drugs are used to prevent against toxicity induced by ch
romium(VI) compounds. (C) 2000 Elsevier Science Ireland Ltd. All rights res
erved.